Impact of tacrolimus versus cyclosporin A on renal function during the first year after heart transplant
ConclusionsIrrespective of everolimus use with low ‐dose CNIs, our analysis using the instrumental variable method showed no differences in renal function as well as graft rejection during the first year after HTx between HTx recipients who received TAC or CsA.
Source: ESC Heart Failure - Category: Cardiology Authors: Yasuyuki Shiraishi,
Eisuke Amiya,
Masaru Hatano,
Toshiomi Katsuki,
Chie Bujo,
Masaki Tsuji,
Daisuke Nitta,
Hisataka Maki,
Junichi Ishida,
Yukie Kagami,
Miyoko Endo,
Mitsutoshi Kimura,
Masahiko Ando,
Shogo Shimada,
Osamu Kinoshita,
Minoru On Tags: Original Research Article Source Type: research
More News: Cardiology | Heart | Heart Failure | Heart Transplant | Prograf | Study | Tacrolimus | Transplant Surgery | Transplants